Clinical Trial Update: Clinical Study of Lewis Antigen Assay Combined With CA19-9 Assay to Assess Prognosis in Patients With Pancreatic Cancer [NA]

View source ↗

Summary

This clinical study is evaluating a Lewis antigen assay combined with CA19-9 to assess prognosis in pancreatic cancer (pancreatic ductal adenocarcinoma) and is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: PDAC | NA | Status: RECRUITING